公司资料
Dermavant Sciences 股价、新闻与催化剂
- 股票代码:
- DRMT
- 交易所:
- NASDAQ
- 行业:
- Biopharma
- 所在地:
- United States
股价为何变动
Current closing-price context is not available for DRMT.
公司概览
业务概览
Dermavant Sciences was a dermatology-focused biotechnology company developing treatments for inflammatory skin disease before being acquired. Its story centered on skin-care innovation and the commercialization potential of differentiated dermatology assets.
所在地与行业分类
Dermavant was headquartered in the United States and traded as a private or strategic biotech asset before acquisition. It sat in dermatology biotechnology.
商业模式特征
The company depended on clinical data, launch readiness, and the ability to translate skin-disease science into a durable commercial product. Investors historically tracked efficacy, safety, and strategic value.
生物医药行业定位
Dermavant belongs to the historical dermatology M&A bucket. It was a high-quality skin-disease platform that ultimately became part of a larger pharma asset set.
未来催化剂
- Dermavant is mostly a legacy / closeout story now, with catalysts limited to any strategic or asset-resolution update. The market is mainly waiting on residual value.
近期新闻
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。